CeriBell (CBLL) to Release Earnings on Tuesday

CeriBell (NASDAQ:CBLL) is expected to issue its quarterly earnings data after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of ($0.32) per share and revenue of $17.55 million for the quarter.

CeriBell Price Performance

CBLL opened at $23.11 on Friday. The company’s fifty day moving average is $23.62. CeriBell has a fifty-two week low of $18.69 and a fifty-two week high of $32.75.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Canaccord Genuity Group lifted their target price on CeriBell from $31.00 to $33.00 and gave the stock a “buy” rating in a report on Monday, December 9th. JPMorgan Chase & Co. assumed coverage on CeriBell in a research note on Tuesday, November 5th. They issued an “overweight” rating and a $32.00 price objective on the stock. William Blair initiated coverage on CeriBell in a research report on Tuesday, November 5th. They set an “outperform” rating for the company. TD Cowen boosted their price target on shares of CeriBell from $31.00 to $36.00 and gave the stock a “buy” rating in a research report on Monday, December 9th. Finally, Canaccord Genuity Group started coverage on shares of CeriBell in a research report on Tuesday, November 5th. They set a “buy” rating and a $30.00 price objective for the company. Six analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $32.60.

CeriBell Company Profile

We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.